Abstract P3-11-05: A phase Ib multi-cohort study of xentuzumab and abemaciclib in patients (pts) with solid tumors and breast cancer (BC) - Initial report of four dose-finding cohorts
Year: 2020
Type: conference-abstract
Source: Cancer Research
Institutions: University of Minnesota, Masonic Cancer Center, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Aichi Cancer Center, Institut Paoli-Calmettes, Hospital Clínic de Barcelona, Institut Curie, Eli Lilly (United States), Boehringer Ingelheim (Spain), Boehringer Ingelheim (Taiwan), Boehringer Ingelheim (China), Yale Cancer Center, Yale University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3010134799